Legal Opinion

Bell v. Lollar

Indiana Court of Appeals

Decided July 17, 2003No. 22A01-0212-CV-475PublishedCited by 9 opinions

1Opinion of the Court

OPINION

VAIDIK, Judge.

Case Summary

Purepac Pharmaceutical Company (Purepac) appeals the trial court’s denial of its motion for summary judgment. Specifically, Purepac contends that Hirshel Lol-lar’s state law claim for failure to warn about the risk of liver damage from combining acetaminophen and alcohol is preempted by federal law governing the labeling of drugs. Because the Food and Drug Administration’s (FDA) regulations governing the labeling of drugs are minimum standards that do not preempt state law, we affirm the trial court’s denial of summary judgment.

Facts and Procedural History

The…

Also in this document: Concurrence.

2Cases cited11 opinions

  1. Medtronic, Inc. v. LohrSupreme Court of the United States · 1996
  2. Hillsborough County v. Automated Medical Laboratories, Inc.Supreme Court of the United States · 1985
  3. Freidline v. Shelby Insurance Co.Indiana Supreme Court · 2002
  4. Savina v. Sterling Drug, Inc.Supreme Court of Kansas · 1990
  5. prod.liab.rep.(cch)p 10,997 Katie Laurel Wells v. Ortho Pharmaceutical CorporationCourt of Appeals for the Eleventh Circuit · 1986

6 more not listed; retrieve them via the Exa API.

3Cited by9 opinions

  1. McDarby v. Merck & Co., Inc.New Jersey Superior Court Appellate Division · 2008
  2. Levine v. WyethSupreme Court of Vermont · 2008
  3. Bartlett v. MUTUAL PHARMACEUTICAL CO., INC.District Court, D. New Hampshire · 2009
  4. Rowe v. Hoffmann-La Roche Inc.New Jersey Superior Court Appellate Division · 2006
  5. HOUSING AUT. OF CITY OF SOUTH BEND v. GradyIndiana Court of Appeals · 2004

4 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API